Global Vaccine Market Poised for Billion Dollar Growth

Jan. 17, 2008 - PRLog -- Vaccines, seen as commodity products earlier, used to be considered a low growth, low margin industry in developed countries and that with no margin at all in developing ones. The prospects of profits were so weak that majority of firms in the business stepped out of it. However, the market is currently at the centre of attraction for all leading pharmaceutical giants, says “Global Vaccine Market Outlook (2007-2010)”, a market research report by RNCOS. The report says that the vaccine market is registering growth rates much faster than the conventional pharma market. And with several blockbuster potential vaccines slated to hit the market in near future, the growth is projected to rise even faster.

The systematic and thorough research studies the global vaccine market to give an insight into its various segments, including Therapeutics Vaccines, Influenza Vaccines, Adult/Travel vaccines, Basic Pediatric Vaccines, Proprietary Pediatric Vaccines, and Enhanced Pediatric Vaccines. The comprehensive analysis of the market has identified pediatric vaccines as the current highest share-holder but future will see a revival of the market when adult, therapeutic and influenza vaccine segments post a rapid growth.  

The RNCOS research evaluates the pediatrics segment, arguably the biggest segment of the vaccine market, elaborately and finds out the reasons why the market share of this segment is expected to decline in future.  

The report also points out that vaccines for cervical cancer will dominate the future sales. Moreover, vaccines for malaria and AIDS will also be made available to the market, however, it will take some time as according to projections, HIV vaccine will not hit the market before 2016.

Based on these trends, the report forecasts that the global vaccine market will surpass the US$ 21 Billion by 2010.

“Global Vaccine Market Outlook (2007-2010)” exhaustively studies the vaccine market at global level, covering the US, Europe, India, and Brazil among others. It gives segment-wise first-hand data on the past and current market performance and underlines the trends anticipated to affect the future growth.

Apart from this, the report also focuses on the market size of various vaccines, like typhoid, West Nile, HIV etc. and gives key financial information on key players.

For more information visit: http://www.rncos.com/Report/IM522.htm
Current Industry News: http://www.rncos.com/Blog/

# # #

About RNCOS:

RNCOS, incorporated in the year 2002, is an industry research firm. It has a team of industry experts who analyze data collected from credible sources. They provide industry insights and analysis that helps corporations to take timely and accurate business decision in today's globally competitive environment.

Website: www.rncos.com/